QA: Homology Medicines Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001661998_2019_Homology_Medicines_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001661998, Homology Medicines Inc.

  xvar xval
0 AssetsCurrent 221,685,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 35,637,000
3 remainder_Assets 1,772,000
4 LiabilitiesCurrent 25,433,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 38,944,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,300,000
9 ResearchAndDevelopmentExpense 47,948,000
10 remainder_Expenses 0
11 remainder_Revenues 3,684,000
12 remainder_NetIncome 4,349,000
13 remainder_ComprehensiveNetIncome -4,000
  yvar yval
0 Assets 259,094,000
1 Liabilities 64,377,000
2 Expenses 65,248,000
3 Revenues 3,684,000
4 StockholdersEquity 194,717,000
5 NetIncome -57,215,000
6 ComprehensiveNetIncome -57,217,000
7 BaseVar 198,378,000
8 EconomicCapitalRatio 1.72

Edgar->Model Mapping

Feature Distribution

Change over Time